SCHEMBL7880966

SCHEMBL7880966

CN(C(=N)N)C(=O)c1cc2ccc(Oc3cccs3)cc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
RXFP1 Q9HBX9 1/20 0.44
FLT3 P36888 4/20 0.40
PDGFRB P09619 2/20 0.40
PDGFRA P16234 2/20 0.40
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
HRH4 Q9H3N8 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
CA2 P00918 1/20 0.34
XDH P47989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882065 0.84 KMT2A (0.53) KMT2AMEN1RXFP1FLT3PDGFRB
SCHEMBL7884774 0.84 KMT2A (0.41) ARKMT2AMEN1RXFP1FLT3
SCHEMBL7885067 0.83 KMT2A (0.43) KMT2AMEN1RXFP1FLT3PDGFRB
SCHEMBL7881186 0.82 RHEB (0.35) ARKMT2AMEN1RXFP1FLT3
SCHEMBL7873591 0.82 KMT2A (0.45) KMT2AMEN1RXFP1FLT3PDGFRB
SCHEMBL7877897 0.82 KMT2A (0.60) KMT2AMEN1RXFP1FLT3PDGFRB
SCHEMBL7877882 0.82 KMT2A (0.45) KMT2AMEN1RXFP1FLT3PDGFRB
SCHEMBL7879945 0.82 KMT2A (0.41) ARKMT2AMEN1RXFP1FLT3
SCHEMBL7884567 0.81 KMT2A (0.43) ARKMT2AMEN1RXFP1FLT3
SCHEMBL7873910 0.81 KMT2A (0.47) ARKMT2AMEN1RXFP1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed